Interestingly, CCL3 and CCL4 enhanced phosphorylation of Btk and NF-κB in DLBCL cells in culture, suggesting that upregulation of these chemokines may be the underlying cause of doxorubicin resistance. The gene discussed is CCL3; the disease is diffuse large B-cell lymphoma.